Copay Savings Can Change the Outcome
You’re already a trusted voice—Patients look to you for guidance when costs feel overwhelming. A simple conversation about copay savings can be the difference between a prescription filled and one abandoned. Our Copay CARE Portal makes it easier.
Here, you’ll find information and resources for patient access programs from Padagis so that you can help your patients get the support they deserve—right when they need it most. Eligible patients with commercial insurance may qualify for copay assistance that can significantly reduce their out-of-pocket costs.
That means:
- Patients can start therapy without delay or financial crisis
- Adherence improves when cost isn’t forcing impossible choices
- You spend less time navigating affordability barriers at the counter
Below, you’ll find the prescription savings offers available from Padagis today.
Rx Savings Offers
These prescription medicines from Padagis are eligible for patient copay savings offers.
Driven by Patients. Inspired by Purpose.
At Padagis, we’re driven by patients and inspired by purpose. The patient experience is at the heart of everything we do—from product development to manufacturing and beyond. Our focus is on delivering high-quality, affordable medicines that make a real difference in people’s lives. Every decision we make reflects our deep commitment to improving access to care, achieving better outcomes, and strengthening trust in healthcare.
As we continue to build Padagis into a leader in the generics market, collaboration is key to our growth strategy.
Through business development and strategic acquisitions, we’re expanding our product portfolio and market presence. Our initiatives include product acquisition and licensing, co-development of complex generics, and private label partnerships that broaden our reach in the US and abroad. We’re also extending our footprint into Europe, Canada, and Latin America while offering contract manufacturing services for nasal and topical dosage forms through our advanced facilities in Israel and the US.
